Bill114th CongressFiled Feb 5, 2015Health
H.Res. 95
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Feb 5, 2015)
Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.
What just happenedFeb 6, 2015
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Vargas, Juan [D-CA-51](D-CA)Sponsor
2 cosponsors2 D
2cosponsors1committees4actions11subjects
- Introduced in HouseFeb 5, 2015
- Feb 6, 2015Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 5, 2015IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 5, 2015IntroReferralIntro-H
Introduced in House
- Feb 5, 2015IntroReferral1000
Introduced in House